Abstract
The Clorox Company will report fiscal first-quarter results on November 2, 2026 Post-Mkt, and this preview summarizes consensus expectations for revenue, earnings and margins alongside segment dynamics and institutional viewpoints shaping near-term expectations.Market Forecast
Based on the company’s latest outlook data, revenue for the current fiscal quarter is projected at 1.88 billion US dollars, implying a 34.02% year-over-year increase, while estimated EBIT is 225.22 million US dollars with a 55.55% year-over-year rise and adjusted EPS is expected at 1.07, up 35.34% year over year. The company has not provided explicit gross profit margin or net margin guidance for this quarter in the data presented, so consensus margin expectations are not detailed here.The company’s main business continues to revolve around cleaning and health-oriented portfolios, with institutional commentary pointing to a near-term mix that reflects ongoing normalization in pricing and volumes and incremental contribution from professional hygiene; last quarter’s Health & Wellness revenue was 860.00 million US dollars, and underlying growth across core categories has been characterized as roughly flat to 1% year over year. The most promising area highlighted by institutions remains the health and hygiene franchise, supported by the integration of professional hygiene assets, with last quarter’s Health & Wellness revenue of 860.00 million US dollars and a company-level revenue growth forecast of 34.02% for the current quarter suggesting a constructive setup for that portfolio even as core category growth remains muted.
Last Quarter Review
In the previous quarter, The Clorox Company delivered revenue of 1.95 billion US dollars (down 2.01% year over year), a gross profit margin of 41.27%, GAAP net profit attributable to the parent company of 163.00 million US dollars, a net profit margin of 8.37%, and adjusted EPS of 1.66 (down 42.16% year over year). A notable feature of the quarter was a 12.83% quarter-on-quarter decline in net profit, reflecting a normalization from prior-period comparisons and category-level volume dynamics amid evolving promotional intensity.By business line, Health & Wellness generated 860.00 million US dollars, Household delivered 524.00 million US dollars, International posted 281.00 million US dollars, Lifestyle contributed 280.00 million US dollars, and Corporate and Other accounted for 3.00 million US dollars; institutional assessments indicated that underlying category growth was approximately flat to 1% year over year for core businesses, with trash bag share gains cited as a partial offset to softness in charcoal and litter.
Current Quarter Outlook
Main business: Health and Wellness
The near-term setup for the company’s health and cleaning portfolios is anchored by an estimated 1.88 billion US dollars of total company revenue in the current quarter and an estimated adjusted EPS of 1.07, underpinned by a meaningful year-over-year expansion in EBIT of 55.55%. Within this mix, Health & Wellness stands out as both the largest and most strategically influential platform, benefiting from continued commercial execution, value superiority initiatives and the integration of professional hygiene offerings. The last quarter’s revenue base of 860.00 million US dollars for this segment provides a sizable denominator for scale efficiencies as productivity programs and procurement savings roll through cost of goods sold.For this quarter, the most relevant drivers in Health & Wellness include pricing normalization, elasticity management, and the cadence of trade promotion support to stabilize volume trends without undermining margin gains captured over the past year. Institutional commentary indicates core category growth has been approximately flat to low-single-digit year over year, placing an emphasis on mix upgrades, innovation throughput, and supply chain execution to protect gross profit dollars. Given the estimated 34.02% year-over-year expansion in total revenue and the 35.34% increase in adjusted EPS implied by the company’s forecast data, a constructive Health & Wellness outcome hinges on sustaining higher-value mix and continued improvement in conversion of gross-to-operating profit amid controlled overhead and disciplined trade investment.
Most promising business: Professional hygiene within Health & Wellness
Institutional previews consistently highlight the incremental contribution from professional hygiene assets, which are embedded within the Health & Wellness umbrella. The integration is important for two reasons: it extends the company’s presence into institutional channels with higher purchase frequency, and it broadens the product architecture into applications where value superiority and brand trust support consistent pricing power. Recent commentary emphasized that professional hygiene performed better than expected, helping underpin management’s confidence in forward revenue growth and providing an offset to slower underlying growth in certain consumer categories.From a revenue standpoint, the last quarter’s Health & Wellness revenue of 860.00 million US dollars demonstrates the scale that the company is building in the category, and the current-quarter forecast for total revenue growth of 34.02% year over year points to a favorable tailwind for businesses tied to hygiene protocols and replenishment-driven demand. The synergy thesis rests on shared procurement, co-development of innovation pipelines, and cross-channel commercial activation that can sustain volume without sacrificing unit economics. Execution risk remains, but the operating structure changes announced mid-year—placing all business units under a single chief operating officer—should streamline accountability and accelerate decision cycles needed to capture the identified growth pockets.
Key stock price driver this quarter: Margin trajectory and category elasticity
In the near term, share performance will likely hinge on how gross profit margin and net profit margin trend relative to last quarter’s 41.27% and 8.37%, respectively, alongside the market’s assessment of durability in EBIT growth. The company’s estimated 55.55% year-over-year increase in EBIT suggests a strong quarter if realized, but investors will parse the quality of the beat by examining price realization versus volume and mix, as well as cost inputs and logistics normalization. Given institutional commentary that underlying category growth is roughly flat to 1% year over year, the balance between promotional intensity and margin protection will be in focus, especially in categories that are price sensitive.Another determinant is segment-level dispersion. Institutional notes have pointed to pressure in charcoal and litter due to weak demand and high inventory, implying that the Lifestyle portfolio could act as a drag if elasticity remains high and promotional lift is modest. Conversely, trash bag share gains provide a positive counterbalance within Household, highlighting the importance of innovation cadence and shelf productivity. The leadership reorganization announced in mid-June—consolidating unit oversight under a chief operating officer and creating a dedicated growth and strategy role—adds a governance layer intended to accelerate execution, which, if visible in the quarter’s trajectory, can support multiple expansion even if headline revenue lands close to forecast.
Analyst Opinions
Among explicit buy/sell calls collected in the period, there were no notable bullish initiations or upgrades and at least one prominent bearish call, while the dominant posture across major institutions was Neutral/Hold with multiple price target reductions; this skews the decisive camp toward a bearish majority when strictly comparing bullish versus bearish stances. On the bearish side, a widely followed institution reiterated a Sell view with an 86.00 US dollars price target, citing caution on category demand, profitability headwinds, and the need for sustained gross margin execution to justify richer valuation. Another institution maintained a sector-perform stance and reduced its price target, flagging weak demand and high inventory as headwinds for charcoal and litter through the grilling season and into fiscal Q1, while noting that the GOJO integration and trash bag share gains provide offsets that temper downside risk.Neutral and equal-weight perspectives from multiple houses consistently converge on a cautious framework: they maintain that the near-term investment case depends on the visibility of margin expansion, the stability of price/volume mix as promotions return to normalized levels, and execution on portfolio optimization. Several firms cut price targets in October, highlighting the sensitivity of earnings power to gross profit margin and the trajectory of Household and Lifestyle volumes, even as Health & Wellness contributes a more resilient revenue stream. This neutral-to-bearish tone is also reinforced by commentary that underlying growth across core categories could be near flat year over year, which places a premium on productivity and innovation to drive incremental unit economics rather than relying on broad-based category tailwinds.
Taking the bearish majority among decisive calls, the core arguments center on three themes that will inform market reaction in this print: first, whether the company can sustain double-digit EBIT growth while protecting gross profit margin without unduly sacrificing volume; second, how much of the 34.02% year-over-year revenue increase is price versus mix and what that implies for elasticity in the subsequent quarters; and third, whether segments facing compression—particularly charcoal and litter—can be stabilized quickly enough to avoid diluting consolidated margin gains. Notably, institutions acknowledge that the professional hygiene acquisition has been performing better than expected and should support sales, but they caution that broader margin guidance and category volumes will ultimately dictate the earnings quality investors are prepared to underwrite.
Market consensus aligning with the company’s own forecast framework implies adjusted EPS of 1.07 and revenue of 1.88 billion US dollars, and bearish-leaning analysts will likely focus less on the magnitude of the beat-or-miss and more on the path: a credible blueprint for maintaining or expanding the last quarter’s 41.27% gross margin would offset concerns about category softness and inventory risk in seasonal lines. Conversely, if the reported net profit margin moves materially away from the last quarter’s 8.37% or if commentary suggests that category promotion is diluting price realization faster than expected, bearish narratives could gain momentum despite progress in Health & Wellness.
In sum, while the prevailing tone across the institutional landscape remains neutral in rating, the explicit buy/sell split tilts bearish due to the absence of upgrades and the presence of at least one Sell recommendation, in tandem with multiple price target reductions. The focus of that majority view is pragmatic rather than pessimistic: it emphasizes gross margin resilience, disciplined commercial execution in price-sensitive categories, and tangible benefits from the reorganized operating model as the central proof points for re-rating potential after the quarter. If the company delivers on its forecast—revenue up 34.02% year over year, EBIT up 55.55%, and adjusted EPS up 35.34%—and pairs this with credible guidance on margin durability and inventory risk, it could soften the bearish case even if ratings themselves remain unchanged in the near term.
Comments